Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Locoregional Recurrence × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 224 Breast Neoplasms 207 Carcinoma, Non-Small-Cell Lung 182 Prostatic Neoplasms 142 Lung Neoplasms 133 Colorectal Neoplasms 126 Neoplasm Metastasis 113 Leukemia, Myeloid, Acute 99 Ovarian Neoplasms 91 Multiple Myeloma 84 Pancreatic Neoplasms 76 Melanoma 69 Endometrial Neoplasms 67 Recurrence 63 Stomach Neoplasms 61 Triple Negative Breast Neoplasms 58 Squamous Cell Carcinoma of Head and Neck 57 Precursor Cell Lymphoblastic Leukemia-Lymphoma 56 Carcinoma, Hepatocellular 53 Uterine Cervical Neoplasms 52 Lymphoma 52 Urinary Bladder Neoplasms 49 Glioblastoma 46 Carcinoma, Renal Cell 45 Brain Neoplasms 42 Lymphoma, Large B-Cell, Diffuse 41 Hematologic Neoplasms 40 Glioma 40 Esophageal Neoplasms 40 Myelodysplastic Syndromes 39

Interventions

ribociclib 1 exemestane 1 Letrozole 1 Fulvestrant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05467891 2026-02-27

RaPhLRR

Hoosier Cancer Research Network

Phase 2 Recruiting

Locoregional Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡